The oncosuppressor p53 suppresses tumor growth and has proapoptotic activity through the transcriptional activation of proapoptotic Bcl-2 family members and repression of other antiapoptotic Bcl-2 family proteins; it also promotes receptor-mediated cell death. Here, TP53 is linked to neoplasm.